PMID: 4033771Aug 22, 1985Paper

Platelet secretory products inhibit lipoprotein metabolism in macrophages

D R PhillipsT L Innerarity


Macrophages possess a receptor that binds low-density lipoproteins (LDL) containing lysine residues modified by acetylation (Ac LDL), acetoacetylation (AcAc LDL) or malondialdehyde treatment. This receptor (referred to as the Ac LDL receptor or scavenger receptor) internalizes the bound lipoprotein. As a consequence, massive amounts of cholesteryl esters accumulate so that macrophages in culture resemble foam cells found in atherosclerotic lesions. In an effort to identify an unmodified mammalian macromolecule that binds to the Ac LDL receptor, we investigated whether platelet secretory products affect the receptor-mediated endocytosis of chemically modified lipoproteins. Platelets are a potential source of such activity because they exist in close association with foam cells in developing atherosclerotic lesions. Our study demonstrates that human blood platelets secrete a product that inhibits the binding and uptake of AcAc LDL by mouse peritoneal macrophages and the subsequent accumulation of cholesteryl esters. This is the first indication that an endogenous macromolecule interacts with Ac LDL receptor on macrophages.


Jan 1, 1979·Proceedings of the National Academy of Sciences of the United States of America·J L GoldsteinM S Brown
Oct 1, 1977·The Journal of Clinical Investigation·I F CharoT C Detwiler
Jan 1, 1983·Annual Review of Biochemistry·M S Brown, J L Goldstein
Jul 1, 1984·Arteriosclerosis : an Official Journal of the American Heart Association, Inc·A FaggiottoL Harker
Jul 1, 1984·Arteriosclerosis : an Official Journal of the American Heart Association, Inc·A Faggiotto, R Ross
Jun 1, 1984·Proceedings of the National Academy of Sciences of the United States of America·U P SteinbrecherD Steinberg
Apr 1, 1980·Proceedings of the National Academy of Sciences of the United States of America·A M FogelmanP A Edwards


Jan 1, 1991·Progress in Lipid Research·J L Kelley
Aug 1, 1987·The Journal of Clinical Investigation·L K CurtissE F Plow
Jan 1, 1989·Journal of Clinical Chemistry and Clinical Biochemistry. Zeitschrift Für Klinische Chemie Und Klinische Biochemie·M AviramG J Brook
Jul 1, 1989·Experimental Lung Research·K McCusker, J Hoidal
Jul 1, 1987·Progress in Cardiovascular Diseases·M Aviram, J G Brook
Jul 1, 1989·Annals of Neurology·F M Yatsu, M Fisher
Jul 31, 1987·Biochemical and Biophysical Research Communications·P J Goldschmidt-ClermontR M Galbraith
Oct 21, 1999·Biochemical and Biophysical Research Communications·M InoueH Nakada
Jul 1, 1992·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·C A Toth, P Thomas
Aug 22, 1985·Nature·M S Brown, J L Goldstein
Jul 1, 1990·Arteriosclerosis : an Official Journal of the American Heart Association, Inc·M AviramJ G Brook
Jan 1, 1996·Arteriosclerosis, Thrombosis, and Vascular Biology·M A van der KooijT J van Berkel
Jun 5, 2001·The Journal of Biological Chemistry·J Santiago-GarcíaR E Pitas

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.